Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) Equity Income (2018 - 2025)

Sanara MedTech's Equity Income history spans 6 years, with the latest figure at -$324734.0 for Q4 2025.

  • For Q4 2025, Equity Income fell 454.54% year-over-year to -$324734.0; the TTM value through Dec 2025 reached -$952466.0, down 26.88%, while the annual FY2025 figure was -$952466.0, 958.21% down from the prior year.
  • Equity Income reached -$324734.0 in Q4 2025 per SMTI's latest filing, down from -$288642.0 in the prior quarter.
  • In the past five years, Equity Income ranged from a high of -$31448.0 in Q3 2024 to a low of -$660678.0 in Q4 2022.
  • Average Equity Income over 4 years is -$224975.9, with a median of -$186806.0 recorded in 2021.
  • Peak YoY movement for Equity Income: crashed 282.95% in 2022, then plummeted 817.84% in 2025.
  • A 4-year view of Equity Income shows it stood at -$144180.0 in 2021, then crashed by 358.23% to -$660678.0 in 2022, then skyrocketed by 91.14% to -$58559.0 in 2024, then crashed by 454.54% to -$324734.0 in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Equity Income are -$324734.0 (Q4 2025), -$288642.0 (Q3 2025), and -$195482.0 (Q2 2025).